CD99 refers to the activity of inflammatory bowel disease

References

• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306.
   PubMed Web of Science ®Google Scholar
• Qiu H, Sun X, Sun M, et al. Serum bacterial toxins are related to the progression of inflammatory bowel disease. Scand J Gastroenterol. 2014;49:826–833.
   PubMed Web of Science ®Google Scholar
• Liu TC, Stappenbeck TS. Genetics and pathogenesis of inflammatory bowel disease. Annu Rev Pathol. 2016;11:127–148.
   PubMed Web of Science ®Google Scholar
• Yang X, Yu L, Yu W, et al. Intestinal wall thickness detected by multidetector spiral computed tomography enterography predicts the disease severity of Crohn's disease. Scand J Gastroenterol. 2014;49:807–813.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Zhu Z, Yang Y, et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013;28:1148–1153.
   PubMed Web of Science ®Google Scholar
• Zhao J, Ng SC, Lei Y, et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "western" disease. Inflamm Bowel Dis. 2013;19:1839–1845.
   PubMed Web of Science ®Google Scholar
• Schenkel AR, Mamdouh Z, Chen X, et al. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol. 2002;3:143–150.
   PubMed Web of Science ®Google Scholar
• Lee EK, Chae JH, Kang MS. Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter. Mol Cells. 2011;32:555–560.
   PubMed Web of Science ®Google Scholar
• Rocchi A, Manara MC, Sciandra M, et al. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. J Clin Invest. 2010;120:668–680.
   PubMed Web of Science ®Google Scholar
• Scotlandi K, Zuntini M, Manara MC, et al. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene. 2007;26:6604–6618.
   PubMed Web of Science ®Google Scholar
• Manara MC, Bernard G, Lollini PL, et al. CD99 acts as an oncosuppressor in osteosarcoma. Mol Biol Cell. 2006;17:1910–1921.
   PubMed Web of Science ®Google Scholar
• Fattal I, Shental N, Mevorach D, et al. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology. 2010;130:337–343.
   PubMed Web of Science ®Google Scholar
• Winger RC, Harp CT, Chiang MY, et al. Cutting edge: CD99 is a novel therapeutic target for control of T cell-mediated central nervous system autoimmune disease. J Immunol. 2016;196:1443–1448.
   PubMed Web of Science ®Google Scholar
• Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670–1689.
   PubMed Web of Science ®Google Scholar
• Yuksel ES, Ipek S, Topal F, et al. Assessment of presence and grade of activity in ileal Crohn's disease. Turk J Gastroenterol. 2014;25:264–270.
   PubMed Web of Science ®Google Scholar
• Tahara T, Shibata T, Okubo M, et al. Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypes. Clin Exp Med. 2015;15:327–332.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang L, Cui Y, et al. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1133–1144.
   PubMed Web of Science ®Google Scholar
• Liu C, Xia X, Wu W, et al. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease. Clin Exp Immunol. 2013;173:102–111.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yadav PK, Xu X, et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol. 2011;89:597–606.
   PubMed Web of Science ®Google Scholar
• Su J, Chen T, Ji XY, et al. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:720–728.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhou G, He C, et al. Serum levels of lipopolysaccharide and 1,3-β-D-glucan refer to the severity in patients with Crohn's disease. Mediators Inflamm. 2015;2015:843089
   PubMed Web of Science ®Google Scholar
• Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut. 2013;62:1653–1664.
   PubMed Web of Science ®Google Scholar
• Zhou G, Song Y, Yang W, et al. ASCA, ANCA, ALCA and many more: are they useful in the diagnosis of inflammatory bowel disease? Dig Dis. 2016;34:90–97.
   PubMed Web of Science ®Google Scholar
• Dufour EM, Deroche A, Bae Y, et al. CD99 is essential for leukocyte diapedesis in vivo. Cell Commun Adhes. 2008;15:351–363.
   PubMed Web of Science ®Google Scholar
• Watson RL, Buck J, Levin LR, et al. Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration. J Exp Med. 2015;212:1021–1041.
   PubMed Web of Science ®Google Scholar
• Lou O, Alcaide P, Luscinskas FW, et al. CD99 is a key mediator of the transendothelial migration of neutrophils. J Immunol. 2007;178:1136–1143.
   PubMed Web of Science ®Google Scholar
• Manes TD, Pober JS. Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells. J Immunol. 2011;186:1763–1768.
   PubMed Web of Science ®Google Scholar
• Bixel G, Kloep S, Butz S, et al. Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood. 2004;104:3205–3213.
   PubMed Web of Science ®Google Scholar
• Chagnon P, Schneider R, Hebert J, et al. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum. 2006;54:1270–1278.
   PubMed Web of Science ®Google Scholar
• Oh KI, Kim BK, Ban YL, et al. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med. 2007;39:176–184.
   PubMed Web of Science ®Google Scholar
• Bernard G, Raimondi V, Alberti I, et al. CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Eur J Immunol. 2000;30:3061–3065.
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.
   PubMed Web of Science ®Google Scholar
• He C, Shi Y, Wu R, Sun M, Fang L, Wu W, et al. miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-alpha in IBD. Gut. 2016;65:1938–1950.
   PubMed Web of Science ®Google Scholar
• Wu W, Chen F, Liu Z, et al. Microbiota-specific Th17 Cells: Yin and Yang in regulation of inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1473–1482.
   PubMed Web of Science ®Google Scholar
• Wu W, Sun M, Zhang HP, et al. Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation. Gut. 2014;63:1883–1892.
   PubMed Web of Science ®Google Scholar